These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31568390)

  • 1. Comparing Glycaemic Benefits of Active Versus Passive Lifestyle Intervention in Kidney Allograft Recipients: A Randomized Controlled Trial.
    Kuningas K; Driscoll J; Mair R; Smith H; Dutton M; Day E; Sharif AA
    Transplantation; 2020 Jul; 104(7):1491-1499. PubMed ID: 31568390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing glycaemic benefits of Active Versus passive lifestyle Intervention in kidney Allograft Recipients (CAVIAR): study protocol for a randomised controlled trial.
    Wilcox J; Waite C; Tomlinson L; Driscoll J; Karim A; Day E; Sharif A
    Trials; 2016 Aug; 17(1):417. PubMed ID: 27550305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.
    Heise T; Mari A; DeVries JH; Urva S; Li J; Pratt EJ; Coskun T; Thomas MK; Mather KJ; Haupt A; Milicevic Z
    Lancet Diabetes Endocrinol; 2022 Jun; 10(6):418-429. PubMed ID: 35468322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Smartphone App on Weight Change and Metabolic Outcomes in Asian Adults With Type 2 Diabetes: A Randomized Clinical Trial.
    Lim SL; Ong KW; Johal J; Han CY; Yap QV; Chan YH; Chooi YC; Zhang ZP; Chandra CC; Thiagarajah AG; Khoo CM
    JAMA Netw Open; 2021 Jun; 4(6):e2112417. PubMed ID: 34081137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S
    Cochrane Database Syst Rev; 2020 Jul; 8(8):CD009966. PubMed ID: 32803882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.
    Taheri S; Zaghloul H; Chagoury O; Elhadad S; Ahmed SH; El Khatib N; Amona RA; El Nahas K; Suleiman N; Alnaama A; Al-Hamaq A; Charlson M; Wells MT; Al-Abdulla S; Abou-Samra AB
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):477-489. PubMed ID: 32445735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a randomised clinical trial.
    Johansen MY; Karstoft K; MacDonald CS; Hansen KB; Ellingsgaard H; Hartmann B; Wewer Albrechtsen NJ; Vaag AA; Holst JJ; Pedersen BK; Ried-Larsen M
    Diabetologia; 2020 Nov; 63(11):2410-2422. PubMed ID: 32816096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation.
    Ravindran VK; Moore RH; Dunseath G; Luzio SD; Owens DR; Baboolal K
    Transplantation; 2009 Jun; 87(12):1870-6. PubMed ID: 19543067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle intervention according to general recommendations improves glucose tolerance.
    Mensink M; Blaak EE; Corpeleijn E; Saris WH; de Bruin TW; Feskens EJ
    Obes Res; 2003 Dec; 11(12):1588-96. PubMed ID: 14694225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial.
    Van Laecke S; Nagler EV; Taes Y; Van Biesen W; Peeters P; Vanholder R
    Transpl Int; 2014 Sep; 27(9):895-902. PubMed ID: 24909487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a lifestyle education program on glycemic control among patients with diabetes at Kigali University Hospital, Rwanda: A randomized controlled trial.
    Amendezo E; Walker Timothy D; Karamuka V; Robinson B; Kavabushi P; Ntirenganya C; Uwiragiye J; Mukantagwabira D; Bisimwa J; Uwintwali Marie H; Umulisa H; Niyomwungeri S; Ndayambaje B; Dusabejambo V; Bavuma C
    Diabetes Res Clin Pract; 2017 Apr; 126():129-137. PubMed ID: 28237859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
    Feig DS; Donovan LE; Zinman B; Sanchez JJ; Asztalos E; Ryan EA; Fantus IG; Hutton E; Armson AB; Lipscombe LL; Simmons D; Barrett JFR; Karanicolas PJ; Tobin S; McIntyre HD; Tian SY; Tomlinson G; Murphy KE;
    Lancet Diabetes Endocrinol; 2020 Oct; 8(10):834-844. PubMed ID: 32946820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose metabolism after renal transplantation.
    Hecking M; Kainz A; Werzowa J; Haidinger M; Döller D; Tura A; Karaboyas A; Hörl WH; Wolzt M; Sharif A; Roden M; Moro E; Pacini G; Port FK; Säemann MD
    Diabetes Care; 2013 Sep; 36(9):2763-71. PubMed ID: 23656979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the DEXLIFE 'self-selected' lifestyle intervention aimed at improving insulin sensitivity in people at risk of developing type 2 diabetes: study protocol for a randomised controlled trial.
    O'Donoghue GM; Kennedy A; Andersen GS; Durkan E; Thybo T; Sinnott M; Nolan JJ; O'Gorman DJ
    Trials; 2015 Nov; 16():529. PubMed ID: 26581687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials.
    Yoon U; Kwok LL; Magkidis A
    Metabolism; 2013 Feb; 62(2):303-14. PubMed ID: 22959500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.
    Kosaka K; Noda M; Kuzuya T
    Diabetes Res Clin Pract; 2005 Feb; 67(2):152-62. PubMed ID: 15649575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic susceptibility, lifestyle intervention and glycemic changes among women with prior gestational diabetes.
    Liang Z; Wang L; Liu H; Chen Y; Zhou T; Heianza Y; Leng J; Li W; Yang X; Shen Y; Gao R; Hu G; Qi L
    Clin Nutr; 2020 Jul; 39(7):2144-2150. PubMed ID: 31542245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus.
    Halden TAS; Kvitne KE; Midtvedt K; Rajakumar L; Robertsen I; Brox J; Bollerslev J; Hartmann A; Åsberg A; Jenssen T
    Diabetes Care; 2019 Jun; 42(6):1067-1074. PubMed ID: 30862658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial.
    Moreira-Lucas TS; Duncan AM; Rabasa-Lhoret R; Vieth R; Gibbs AL; Badawi A; Wolever TM
    Diabetes Obes Metab; 2017 Jan; 19(1):133-141. PubMed ID: 27717236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.